Skip to main content

Table 5 Independent association between PLR and DR

From: Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history

Exposure Model Model I Model II
PLRgroup OR (95%CI) P OR (95%CI) P OR (95%CI)
Continuous PLR 1.06 (1.01,1.10) 0.013* 1.04 (0.99,1.09) 0.109 1.05 (0.99, 1.11) 0.135
2.75–7.98 1 1 1
7.99–10.34 1.65 (0.98, 2.76) 0.058 1.86 (1.06, 3.27) 0.031* 1.37 (0.70, 2.71) 0.360
10.36–13.40 1.17 (0.70, 1.94) 0.558 1.34 (0.77, 2.34) 0.307 0.95 (0.47, 1.92) 0.891
13.49–35.26 2.51 (1.47, 4.27) 0.000** 2.15 (1.20, 3.85) 0.001** 2.20 (1.05, 4.59) 0.037*
P for trend 0.003** 0.033* 0.073
  1. Model: crude model; Model I: adjusting for age, gender, diabetes duration; Model II: adjusting for age, gender, diabetes duration, hypertension, BMI, Scr, WBC, Hb, BUN, TG, FPG and HbA1c
  2. PLR platelet-to-lymphocyte ratio, OR odds ratios, CI confidence intervals, BMI body mass index, Scr serum creatinine, WBC white blood cell, Hb hemoglobin, BUN blood urea nitrogen, TG triglycerides, FPG fasting plasma glucose, HbA1c glycated hemoglobin A1c
  3. *P < 0.05, **P < 0.01